AKT1 and familial pancreatic carcinoma: Inactivation of the ERK signaling pathway activates the PI3K/AKT signaling pathway in various tumors, and the PI3K/AKT signaling pathway in turn, could promote cell survival, inhibit apoptosis, and induce drug resistance in pancreatic cancer [11, 28].